Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 2018

View Archived Issues

Kinase interplay prevents ALS

Parkin, PINK keep inflammation pout of the red zone

Brain-on-three-chips includes BBB

Unexpected asthma mechanism changes targeting calculus

Nilotinib improves biomarkers of Parkinson's disease in phase II study

Koligo introduces Kyslecel to preserve insulin secretory capacity after total pancreatectomy

Lawrence Livermore National Laboratory develops nerve agent antidote LLNL-02

EGFR tyrosine kinase inhibitor from UCLA crosses the blood-brain barrier

Xarelto receives approval in the E.U. for the treatment of patients with artery disease

University of Michigan describes bromodomain and extra-terminal protein inhibitors

Seoul National University patents 4'-phosphopantetheinyl transferase inhibitors

G-0775: An arylomycin class Gram-negative antibiotic

Zai Lab discontinues development of ZL-3101 for atopic dermatitis

European Commission approves Vyxeos for two types of high-risk AML

Evotec and Centogene establish drug discovery collaboration in rare genetic diseases

European Commission approves Kymriah

Yescarta approved in E.U. for relapsed or refractory DLBCL and PMBCL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...